INVVY News and Press, Indivior PLC ADR From 05/15/20

Indivior PLC (INVVY) Q1 2020 Results Conference Call May 14, 2020 08:00 AM ET Company Participants Shaun Thaxter - CEO Mark Crossley - Chief Financial and Operations Officer Christian Heidbreder - Chief Scientific Officer Javier Rodriguez - Chief Legal Officer Conference Cal...

SLOUGH, England and RICHMOND, Va. , May 14, 2020 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that its Q1 2020 press release is now available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's website at www.indi...

SLOUGH, England and RICHMOND, Va. , April 16, 2020 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication of long-term safety data for SUBLOCADE® (buprenorphine extended-release) injection, for subcutaneous use (CIII).  The manuscri...

SLOUGH, England and RICHMOND, Va. , March 23, 2020 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication of one-year outcomes from a 24-month real-world observational study, RECOVER™ (Remission from Chronic Opioid Use—Studying Environmental and Socio-...

Indivior PLC (INVVY) Q4 2019 Earnings Conference Call February 13, 2020 6:30 A.M. ET Company Participants Shaun Thaxter - Chief Executive Officer and Executive Director Mark Crossley - Chief Financial and Operations Officer and Executive Director Javier Rodriguez - Chief Legal Of...

The following slide deck was published by Indivior PLC in conjunction with their 2019 Q4 earnings Read more ...

SLOUGH, United Kingdom and RICHMOND, Va. , Feb. 13, 2020 /PRNewswire/ --   Indivior PLC (LON: INDV) today announced that its full year 2019 press release is now available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's w...

SLOUGH, England and RICHMOND, Va , Dec. 10, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced a new research collaboration with Virginia Tech extending the RECOVER (Remission from Chronic Opioid Use-Studying Environmental and Socio-Economic Factors on Recovery) Study &#...

SLOUGH, England and RICHMOND, Va. , Dec. 2, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) announced today that new analysis from a 12-month investigation of monthly buprenorphine extended-release injections showed that study participants who were treated with SUBLOCADE® (bu...

RICHMOND, Va. , Nov. 11, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) announces the launch of a new direct-to-consumer (DTC) advertising campaign, Keep Moving Towards Recovery , which aims to heighten awareness of treatment with SUBLOCADE® (buprenorphine extended-release) injection...